Penn Medicine Abramson Cancer Center


 

bsAb and IO for R/R MM in 2021: Are Teclistamab, Talquetamab, & Cevostamab Showing Promising Activity?

24 views
March 2, 2021
0 Comments
Login to view comments. Click here to Login